PKM and cancer: However, at variance with the constitutively active (i.e., tetrameric) PKM1 isoform, PKM2 is mainly present in a dimeric form, which is much less active in catalyzing the last step within glycolysis, thus favoring accumulation of upstream glycolytic metabolites, as occurs in cancer cells [61].